US 9,175,003 B2 · Substituted azoanthracene derivatives and intermediates for preparation thereof

Substituted azoanthracene derivatives and intermediates for preparation thereof

AssigneevTv Therapeutics LLC

InventorsAdnan M. M. Mjalli, Christopher Behme, Daniel P. Christen, Devi Reddy Gohimukkula, Dharma Rao Polisetti, James C. Quada, Jr., Jennifer L. R. Freeman, Muralidhar Bondlela, Mustafa Guzel, Ravindra Reddy Yarragunta, Robert Carl Andrews, Santhosh Kalpathy, Stephen Thomas Davis, Thomas Scott Yokum

Life of this patent

Estimating the term…

Abstract

The present invention relates to substituted azoanthracene derivatives and intermediates for the preparation thereof. The substituted azoanthracene derivatives and associated intermediates may be useful for the preparation of pharmaceutical compositions for the treatment or prevention of diseases, disorders, and conditions wherein modulation of the human GLP-1 receptor is beneficial.

Claims11

Dependent claims

A compound of the formula:

wherein
R1 is hydrogen or methyl, and
R2 is —CO2-tert-butyl, or -1-(phenyl)-propyl.

Dependencies are inferred from the claim text.

Facts

Application

14/603,556Filed 23 Jan 2015 · continuation

Priority

30 Mar 2009

Published

US 2015/0148539 A128 May 2015

Granted

3 Nov 2015

Term ends

Not estimatedThe source records don’t support an estimate.

Classification17 codes

C07D 491/056
Ortho-condensed systems: with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
A61P 3/00
Drugs for disorders of the metabolism
A61P 3/04
Drugs for disorders of the metabolism: anorexiants; Antiobesity agents
A61P 3/06
Drugs for disorders of the metabolism: antihyperlipidemics

Family

Application61/164,523Us provisional application · filed 30 Mar 2009

Application61/309,348Us provisional application · filed 1 Mar 2010

PCT/US2010/029172Parent of this continuation · filed 30 Mar 2010

Application12/825,631Parent of this division · filed 29 Jun 2010

Application13/707,265Parent of this continuation · filed 6 Dec 2012

US 8,383,644 B2Parent of this division · filed 26 Feb 2013

US 2015/0148539 A1Pre-grant publication · published 28 May 2015

US 8,987,295 B2Parent of this continuation

Application13/707,265Parent of this division

Application12/825,631Parent of this continuation

US 2011/0160198 A1Published application

US 2013/0096150 A1Published application

US 9,175,003 B2This patent

From the US filing history. Foreign family members aren’t listed.